76 (2005) For more Therapeutic Uses (Complete) data for L-CARNITINE (29 total), please visit the HSDB record page
Nevertheless, the pooled analysis of 16 trials suggested improvements in the summary measure of patients' global functioning (assessed with the Clinical Global Impressions [CGI-I] scale) after 12 and 24 weeks of (but not after 52 weeks) of ALCAR treatment (1-3 g/day) and in cognitive performance (assessed with the Mini-Mental State Examination [MMSE] scale) after 24 weeks (but not at 12 or 52 weeks) (104)
Additionally, it can strengthen the immune system, providing robust resistance against various diseases
[68] [69] However, a 2025 meta-analytic systematic review of 113 randomized controlled trials found that stimulant medications were the only intervention with robust short-term efficacy, and were associated with lower all-cause treatment discontinuation rates than non-stimulant medications (e.g., atomoxetine)
Pathmanathan, K., Robinson, P
La L-Carnitine est un acide amin trs prsent dans les formules de brleurs de graisses et est souvent surnomm transporteur de graisses